EC Dental Science

Periodontal disease is a chronic microbial infection that triggers inflammation-mediated loss of the periodontal ligament and alveolar bone that supports the teeth. Because of the increasing prevalence and associated comorbidities, there is a need for the development of new diagnostic tests that can detect the presence of active disease, predict future disease progression, and evaluate the response to periodontal therapy, thereby improving the clinical management of periodontal patients. The diagnosis of active phases of periodontal disease and the identification of patients at risk for active disease represent challenges for clinical investigators and practitioners. Advances in diagnostic research are moving toward methods whereby the periodontal risk can be identified and quantified by objective measures using biomarkers. Patients with periodontitis may have elevated circulating levels of specific inflammatory markers that can be correlated to the severity of the disease. Advances in the use of oral fluids as possible biological samples for objective measures of the current disease state, treatment monitoring, and prognostic indicators have boosted saliva- and other oral-based fluids to the forefront of technology. This article highlights recent Research methodology and advances in the use of biomarker-based disease diagnostics that focus on the identification of active periodontal disease from plaque biofilms, GCF, and saliva so as to move towards precision periodontics.

Keywords: Periodontitis; Biomarkers; Diagnostic Aid; Precision; Research

1. Bartold P and Ivanovski Sašo. “P4 Medicine as a model for precision periodontal care”. Clinical Oral Investigations9 (2022): 5517-5533.
2. Miller CS., et al. “Salivary biomarkers for discriminating periodontitis in the presence of diabetes”. Journal of Clinical Periodontology2 (2021): 216-225.
3. Kim S., et al. “Metabolic phenotyping of saliva to identify possible biomarkers of periodontitis using proton nuclear magnetic resonance”. Journal of Clinical Periodontology9 (2021): 1240-1249.
4. Katsiki P., et al. “Comparing periodontitis biomarkers in saliva, oral rinse and gingival crevicular fluid: A pilot study”. Journal of Clinical Periodontology9 (2021): 1250-1259.
5. Hentenaar DFM., et al. “Biomarker levels in peri-implant crevicular fluid of healthy implants, untreated and non-surgically treated implants with peri-implantitis”. Journal of Clinical Periodontology4 (2021): 590-601.
6. Deng K., et al. “Diagnostic accuracy of a point-of-care aMMP-8 test in the discrimination of periodontal health and disease”. Journal of Clinical Periodontology 8 (2021): 1051-1065.
7. Sharma P., et al. “Oxidative stress links periodontal inflammation and renal function”. Journal of Clinical Periodontology 3 (2021): 357-367.
8. Rojas Mariana., et al. “Gene expression profiles of oral soft tissue derived fibroblasts from healing wounds: correlation with clinical outcome, autophagy activation and fibrotic markers expression”. Journal of Clinical Periodontology5 (2021): 705-720.
9. Costa FO., et al. “Effect of compliance during periodontal maintenance therapy on c-reactive protein levels: a 6-year follow-up”. Journal of Clinical Periodontology 3 (2021): 400-409.
10. Rakic M., et al. “A Roadmap towards Precision Periodontics”. Medicina 57 (2021): 233.